Oral: Dose individualisation – focus on biomarkers

A pharmacometric framework for dose individualisation of sunitinib in GIST

Thursday 16 October, 2025

Objectives:  The rise of targeted cancer therapies has revolutionized the field of oncology, however, uncertainties remain regarding their best dosing…

Read more

Use of mathematical modeling for optimizing and adapting immunotherapy protocols in HIV-infected patients

Thursday 16 October, 2025

Objectives: In some cases, HIV-infected patients under antiretroviral therapy fail to restore their immune system and especially CD4+ T lymphocytes…

Read more

Model-based Dose Individualization Approaches Using Biomarkers

Thursday 16 October, 2025

Objectives: This presentation aims at describing how modeling framework incorporating biomarker data can be a valuable tool for dose individualization…

Read more

Experiences in applied clinical pharmacometrics: challenges, recommendations, and research opportunities

Thursday 16 October, 2025

Background: Pharmacometric research has produced a wealth of advanced modeling techniques and models that could be applied in clinical practice…

Read more

Meeting clinicians’ and patients’ needs in the practice of therapeutic monitoring

Thursday 16 October, 2025

Objectives:  To heighten awareness of the clinical importance of Pharmacometrics for elaborating efficient strategies of treatment individualization at the patient’s…

Read more